Less than 1 min.Read

First Approach in Pharma

August 5, 2017

[wpfilebase tag=file id=93 tpl=download-button /]

Inside this Issue

1. Incentivizing a Patient-First Approach in Indian Pharma - interview with Annaswamy Vaidheesh
A conversation with Annaswamy Vaidheesh, Vice President, OPPI, VP, South Asia & Managing Director, India, GSK on GSKs initiatives to meet the demands of Indian pharma in the digital age while putting the patient first

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Topics

Soft Power and the Physician

Draft Pharma Policy

First Approach in Pharma

Inside this Issue

Free Membership Required

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Pharmacy of the World Pricing Paradox

Topics

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Pharmacy of the World Pricing Paradox

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

MedicinMan Pharma Pulse: August 2026

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Related Articles

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

Strategic Communications for Healthcare Brands

Fostering Thought leadership in Healthcare

Sales View – On-the-Go Information, Insights & Learning for Pharma Professionals

Company

Headlines

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Newsletter